Clinical Trials Directory

Trials / Completed

CompletedNCT01981746

Adductor Canal Block and Effect of 10 Versus 30 ml Ropivacaine on Muscle Strength: a Randomized Study in Healthy Volunteers

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
26 (actual)
Sponsor
Rigshospitalet, Denmark · Academic / Other
Sex
Male
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

To investigate whether reducing the volume (30 versus 10 ml) ropivacaine injected can reduce the number of subjects with impaired muscle strength following adductor canal block. We hypothesized that adductor canal block with 10 ml 0.1% ropivacaine preserves quadriceps strength compared with an adductor canal block with 30 ml.

Conditions

Interventions

TypeNameDescription
PROCEDUREAdductor canal block with ropivacaine 0.1%US-guided adductor canal block

Timeline

Start date
2013-11-01
Primary completion
2013-12-01
Completion
2013-12-01
First posted
2013-11-11
Last updated
2014-01-10

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01981746. Inclusion in this directory is not an endorsement.